Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci

Arjan Buijs, PhD, Saskia van der Crabben, MD, PhD, Bert van der Zwaag, PhD, Ellen van Binsbergen, MSc, Martin Poot, PhD, Okke de Weerdt, Marielle van Gijn, PhD, H. Karel Nieuwenhuis, MD, PhD

Blood (2010) 116 (21): 4851.

https://doi.org/10.1182/blood.V116.21.4851.4851

Published: 2010

Journal Articles

The Role of GBPIalpha in Phagocytosis of Platelets by Macrophages.

Bahram Alamdary Badlou, PhD, Gerit Spierenburg, Hans Ulricht, PhD, Hans Deckmyn, PhD, W. Martin Smid, MD, J.W.N. Akkerman, PhD, H. Karel Nieuwenhuis

Blood (2006) 108 (11): 3958.

https://doi.org/10.1182/blood.V108.11.3958.3958

Published: 2006

Journal Articles

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired α IIb β 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation

Ton Lisman, Sultana Moschatsis, Jelle Adelmeijer, H. Karel Nieuwenhuis, Philip G. De Groot

Blood (2003) 101 (5): 1864–1870.

https://doi.org/10.1182/blood-2002-09-2761

Published: 2003

Journal Articles

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A

Ton Lisman, Laurent O. Mosnier, Thierry Lambert, Evelien P. Mauser-Bunschoten, Joost C. M. Meijers, H. Karel Nieuwenhuis, Philip G. de Groot

Blood (2002) 99 (1): 175–179.

https://doi.org/10.1182/blood.V99.1.175

Published: 2002

Journal Articles

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency

Richard van Wijk, Karel Nieuwenhuis, Marijke van den Berg, Eric G. Huizinga, Brenda B. van der Meijden, Rob J. Kraaijenhagen, Wouter W. van Solinge

Blood (2001) 98 (2): 358–367.

https://doi.org/10.1182/blood.V98.2.358

Published: 2001

Journal Articles

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma

Leo F. Verdonck, Adriaan W. Dekker, Henk M. Lokhorst, Eefke J. Petersen, H. Karel Nieuwenhuis

Blood (1997) 90 (10): 4201–4205.

https://doi.org/10.1182/blood.V90.10.4201

Published: 1997

NARROW

A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci

The Role of GBPIalpha in Phagocytosis of Platelets by Macrophages.

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired α IIb β 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma

Email alerts

ASH Publications

American Society of Hematology

A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci

The Role of GBPIalpha in Phagocytosis of Platelets by Macrophages.

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired α IIb β 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only